Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) on Monday, plunged -4.32% from the previous trading day, before settling in for the closing price of $39.78. Within the past 52 weeks, TNXP’s price has moved between $6.76 and $550.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 92.54%. With a float of $7.32 million, this company’s outstanding shares have now reached $7.32 million.
The firm has a total of 81 workers. Let’s measure their productivity. In terms of profitability, gross margin is 29.81%, operating margin of -721.51%, and the pretax margin is -1146.27%.
Tonix Pharmaceuticals Holding Corp (TNXP) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tonix Pharmaceuticals Holding Corp is 0.07%, while institutional ownership is 6.61%. The most recent insider transaction that took place on May 15 ’25, was worth 86,200. In this transaction Chief Executive Officer of this company bought 4,000 shares at a rate of $21.55, taking the stock ownership to the 4,005 shares.
Tonix Pharmaceuticals Holding Corp (TNXP) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 92.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 88.07% during the next five years compared to 46.06% growth over the previous five years of trading.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Trading Performance Indicators
Tonix Pharmaceuticals Holding Corp (TNXP) is currently performing well based on its current performance indicators. A quick ratio of 11.64 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 27.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -32.12, a number that is poised to hit -6.83 in the next quarter and is forecasted to reach -6.08 in one year’s time.
Technical Analysis of Tonix Pharmaceuticals Holding Corp (TNXP)
Analysing the last 5-days average volume posted by the [Tonix Pharmaceuticals Holding Corp, TNXP], we can find that recorded value of 1.65 million was better than the volume posted last year of 1.41 million. As of the previous 9 days, the stock’s Stochastic %D was 84.22%. Additionally, its Average True Range was 3.74.
During the past 100 days, Tonix Pharmaceuticals Holding Corp’s (TNXP) raw stochastic average was set at 60.73%, which indicates a significant decrease from 79.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 147.54% in the past 14 days, which was lower than the 217.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.28, while its 200-day Moving Average is $21.31. Now, the first resistance to watch is $40.06. This is followed by the second major resistance level at $42.05. The third major resistance level sits at $43.70. If the price goes on to break the first support level at $36.42, it is likely to go to the next support level at $34.77. Now, if the price goes above the second support level, the third support stands at $32.78.
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Key Stats
Market capitalization of the company is 278.78 million based on 7,325K outstanding shares. Right now, sales total 10,090 K and income totals -130,040 K. The company made 2,430 K in profit during its latest quarter, and -16,830 K in sales during its previous quarter.
